Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bischofberger

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Virology|November 18, 2000
Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaquesM S Smith, L Foresman, G J Lopez, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoN Bischofberger, M J Hitchcock, M S Chen, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Journal of Virology|October 6, 1997
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionM A Nowak, A L Lloyd, G M Vasquez, et al.
Journal of the American Chemical Society|January 29, 1997
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activityC U Kim, W Lew, M A Williams, et al.
Journal of Medical Primatology|December 11, 1999
An anti-HIV strategy combining chemotherapy and therapeutic vaccinationB Rosenwirth, W M Bogers, I G Nieuwenhuis, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Nature Medicine|October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaquesZ Hel, D Venzon, M Poudyal, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Virology|November 18, 2000
Lasting effects of transient postinoculation tenofovir [9-R-(2-Phosphonomethoxypropyl)adenine] treatment on SHIV(KU2) infection of rhesus macaquesM S Smith, L Foresman, G J Lopez, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivoN Bischofberger, M J Hitchcock, M S Chen, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Journal of Virology|October 6, 1997
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infectionM A Nowak, A L Lloyd, G M Vasquez, et al.
Journal of the American Chemical Society|January 29, 1997
Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activityC U Kim, W Lew, M A Williams, et al.
Journal of Medical Primatology|December 11, 1999
An anti-HIV strategy combining chemotherapy and therapeutic vaccinationB Rosenwirth, W M Bogers, I G Nieuwenhuis, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Nature Medicine|October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaquesZ Hel, D Venzon, M Poudyal, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
Pageof 6